Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Cash flows from operating activities
Net loss				$ (27,993,848)	$ (19,100,527)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization				2,107,323	1,622,922
Noncash interest expense				2,967,775	1,714,543
Noncash interest income					(87,233)
Stock compensation expense				668,374	155,030
Gain on extinguishment of debt				(259,353)
Inducement expense related to warrant reprice		$ 7,755,541		7,755,541
Change in fair value of derivative liabilities				122,572	(548,008)
Impairment of right-of-use asset				170,714
Impairment of intangible assets					750,596
Changes in operating assets and liabilities, net of acquisition
Accounts receivable				(118,755)	649,079
Inventory				(1,891,760)	(348,484)
Other assets				(353,371)	754,484
Accounts payable				(667,480)	(1,037,810)
Accrued compensation and other liabilities				(188,322)	(166,753)
Deferred revenue				(9,808)	(816,006)
Net cash used in operating activities				(17,690,398)	(16,458,167)
Cash flows from investing activities
Acquisition of business, net of cash acquired of $1,266,849					1,266,849
Note receivable					(2,200,000)
Purchases of property and equipment				(1,824,765)	(2,455)
Net cash used in investing activities				(1,824,765)	(935,606)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs					14,982,663
Proceeds from issuance of common stock warrants				255,751
Proceeds from issuance of common stock and pre-funded warrants in registered offering, net of selling costs				23,473,962
Proceeds from the exercise of common stock warrants, net of issuance costs				9,094,172	8,682,000
Proceeds from debt, net of issuance costs					1,871,308
Payment of deferred offering costs				(108,794)
Payments on debt				(441,076)	(853,063)
Payments on finance lease obligations				(236,563)	(467,592)
Net cash provided by financing activities				32,037,452	24,215,316
Effects of exchange rates on cash				(727,477)	1,066,898
Net increase in cash and cash equivalents and restricted cash				11,794,812	7,888,441
Cash and cash equivalents and restricted cash at beginning of period		$ 14,107,255		14,107,255	2,893,603	$ 2,893,603
Cash and cash equivalents and restricted cash at end of period	$ 25,902,067		$ 10,782,044	25,902,067	10,782,044	$ 14,107,255
Supplemental disclosure of cash flow information
Cash paid for interest				886,796	118,540
Supplemental disclosures of noncash operating, investing, and financing activities
Right-of-use assets acquired through operating leases				748,294
Inventory transferred to property and equipment				559,230
Shares issued in business combination					4,847,417
Shares issued to settle convertible notes					$ 1,450,797